课题基金 / 基金详情

The development of a nanotechnology enabled anti-viral face mask (NanoMask)

The development of a nanotechnology enabled anti-viral face mask (NanoMask)
开发纳米技术抗病毒口罩(NanoMask)
批准号:
63429
负责人:
金额:
$6.36万
依托单位:
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
英国医学会进行的一项调查发现,在高危环境中工作的医生中,有一半无法获得适当的口罩。此外,英国牙医协会对英国牙医每周可以戴250个口罩的典型牙医表示遗憾,现在无论执业规模大小,他们都被限制在100个口罩之内。HSE和PHE在3月27日发表的一项关于个人防护用品在卫生保健环境中使用的研究报告建议使用FFP3,但如果没有,可以使用FFP2和N95口罩。然而,英国没有口罩的认证制造,只有一家生产纺粘和熔喷非织造医用面料的制造商,这种面料用于FFP2/N95一次性呼吸器。Pharm2Farm(Lead)和Flexotronix(分包商)的目标是结合他们领先的纳米技术能力,生产高度增强的抗病毒口罩,以满足N95/FFP 2和FFP 3的规格。
英文摘要
A survey conducted by the British Medical Association found that half of doctors working in high risk environments do not have access to appropriate face masks. Also, the British Dental Association has lamented the typical UK dentist who can go through 250 face masks per week is now restricted to 100 no matter the practice size. A study by HSE and PHE on the use of PPE in health care settings published on the 27th of March recommended the use of FFP3 but if not available FFP2 and N95 masks can be used. However, there is no certified manufacturing of face masks in the UK and there is only one manufacturer of spunbond and meltblown nonwoven medical fabrics, a material used for FFP2/N95 disposable respirators.Pharm2Farm (Lead) and Flexotronix (subcontractor) aim to combine their leading nanotechnology capabilities to produce a highly enhanced anti-viral face mask to meet N95/FFP2 and FFP3 specifications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金